Search clinical trials for: Beta Carotene

Total 6044 results

Hasselt University

Completed

Carnosine Loading and Periodized Training in MS and HC

Multiple Sclerosis | Exercise Therapy | Dietary Supplement

Belgium
Odense University Hospital

Completed

Dandelion Juice in the Treatment of Dyshidrotic Hand Eczema

Vesicular Palmoplantar Eczema | Pompholyx

Denmark
University of Sao Paulo

Completed

24-Wk β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males

Sports Nutritional Physiological Phenomena
Hoffmann-La Roche

Completed

A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal Anemia

Anemia

Bulgaria
ART Fertility Clinics LLC
Organon and Co

Recruiting

Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells

Infertility | Fertility Issues | Infertility,Female | Ovarian Function Insufficiency

United Arab Emirates
Genentech, Inc.
Roche Pharma AG

Completed

A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

United States, Canada, Belgium, Spain, France, Switzerland, Ukraine, Mexico, Germany, Bulgaria, United Kingdom, Romania, Czechia, Italy, Russian Federation, Serbia, Slovakia, Denmark
Southern Illinois University
Astellas Scientific & Medical Affairs, Inc.; Sisters of the Third Order of...

Completed

Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)

Lower Urinary Tract Symptoms | Nocturia

United States
Hamad Medical Corporation

Completed

Comparison Among Erythropoietin Stimulating Agents

Anemia of End Stage Renal Disease

Qatar
Biogen

Completed

Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis (PROOF)

Multiple Sclerosis

United States, Australia, Austria, Canada
Biogen

Completed

Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe

Multiple Sclerosis
Zhejiang Provincial People's Hospital

Recruiting

Effect of Mirabegron on Promoting Brown Adipose Tissue Activation

Tumour

China
Ryerson University
Mitacs; Lucid, Inc.

Completed

The Effects of Music & Auditory Beat Stimulation on Anxiety

Anxiety

Canada
Hannover Medical School
Charite University, Berlin, Germany

Unknown

Cardiovascular Effects of Selective I(f)-Channel Blockade

Postural Orthostatic Tachycardia Syndrome

Germany
Purdue University

Recruiting

Comparing the Adaptation of Commercial Milk and A2 Milk in Lactose Maldigesters

Lactose Intolerance

United States
Purdue University

Recruiting

Comparing the Inflammation, Maldigestion and Symptoms Due to Commercial Milk and A2 Milk

Lactose Intolerance

United States
Peking Union Medical College Hospital

Not yet recruiting

Mirabegron Combined With Behavioral Intervention for Overactive Bladder：a Prospective Multicenter Randomized Controlled Clinical Study

Overactive Bladder
CHU de Quebec-Universite Laval

Completed

Add-on Mirabegron in Pediatric Patients With Refractory Overactive Bladder (Add-on-Mira)

Overactive Bladder | Urinary Incontinence
Centre Hospitalier Universitaire Vaudois
BioPartners GmbH

Completed

Phase I BP Interferon (IFN) Beta-001

Multiple Sclerosis, Relapsing-Remitting
Cedars-Sinai Medical Center

Recruiting

Coronary Atherosclerosis T1-Weighted Characterization (CATCH) (CATCH)

Coronary Atherosclerosis

United States
EMD Serono
Pfizer

Completed

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Relapsing-remitting Multiple Sclerosis

United States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
Merck KGaA, Darmstadt, Germany
Merck Serono S.P.A., Italy

Completed

Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a (CONTAIN)

Multiple Sclerosis

Italy
University Hospital Inselspital, Berne
PharmaPart; Laboratory: Viollier AG Spalenring 145 / 147 Postfach 4002 Basel

Completed

Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b (SWABIMS)

Multiple Sclerosis

Switzerland
OHSU Knight Cancer Institute
Oregon Health and Science University; Kuni Foundation

Recruiting

Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA Melanoma

Clinical Stage IIA Cutaneous Melanoma AJCC v8

United States
Children's Hospital of Philadelphia

Recruiting

Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

Lymphoma | Leukemia | Myelodysplasia

United States
Hoffmann-La Roche

Completed

COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.

Anemia

Australia
PATH
Walter Reed Army Institute of Research (WRAIR); Kenya Medical Research Institute

Completed

Evaluation of the MBio Combined Syphilis/HIV Point-of-Care Diagnostic Test (MBIO)

HIV | Syphilis

Kenya
Biogen

Completed

A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal Impairment & Healthy Volunteers

Healthy | Renal Insufficiency
Chonbuk National University Hospital

Completed

Efficacy and Safety of Fermented Barley on Decrement of Body Fat in Obese Subjects

Overweight; Hyperlipidemia

Korea, Republic of
Nestlé
University Hospital Inselspital, Berne; University of Bern

Completed

Effect of β-alanine Supplementation on Muscle Carnosine (LitmusMagnet)

Healthy

Switzerland
University of Ulm

Recruiting

Efficacy and Tolerability of Beta Hydroxybutyrate Ester in Patients With Amyotrophic Lateral Sclerosis (ALS) (KETO-ALS)

Amyotrophic Lateral Sclerosis

Germany
National Institute of Mental Health (NIMH)

Recruiting

Effects of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-Withdrawal-Induced Mood Symptoms in Women With Past Perimenopausal Depression

Perimenopause-Related Depression

United States
BIO-CAT, Inc.
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

Safety and Tolerability Trial of Microbial Inulinase

Gastrointestinal Health | Digestive Health

Canada
Fakultas Kedokteran Universitas Indonesia

Unknown

Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis

Ulcerative Colitis

Indonesia
Kemin Foods LC
KGK Science Inc.

Completed

Ability of a Euglena Beta Glucan Supplementation to Augment Immune Function

Symptoms Flu | Symptoms Cold

Canada
Hoffmann-La Roche

Completed

An Observational Study of Methoxy Polyethylene Glycol-epoetin Beta in Participants With a Kidney Transplant

Anemia, Kidney Transplantation

Germany
Taipei Veterans General Hospital, Taiwan

Recruiting

Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial

Overactive Bladder Syndrome

Taiwan
Purdue University

Completed

Comparing the Gastric Transit of Commercial Milk and A2 Milk

Lactose Intolerance, Adult Type

United States
Southern Illinois University
Astellas Scientific & Medical Affairs, Inc.; Sisters of the Third Order of...

Terminated

Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement

Pain | Urinary Bladder, Overactive | Lower Urinary Tract Symptoms

United States
University of Florida
National Institute of General Medical Sciences (NIGMS)

Terminated

Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure

Pulmonary Hypertension | Heart Failure With Preserved Ejection Fraction | Diastolic Heart Failure

United States
Benha University

Completed

Dose Esmolol Infusion Have an Adjuvant Effect to TAP Block for Pain Control in Laparoscopic Cholecystectomy.

Postoperative Pain

Egypt
The University of Texas Health Science Center at...

Completed

Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron (SCIMYR)

Cognitive Change | Spinal Cord Injuries | Neurogenic Bladder

United States
Loyola University
Astellas Pharma US, Inc.

Completed

Mirabegron and Urinary Urgency Incontinence

Overactive Bladder

United States
Buddhist Tzu Chi General Hospital

Unknown

Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

Overactive Bladder Syndrome

Taiwan
Biocad

Completed

Pharmacokinetics and Pharmacodynamics Study of BCD-033 Compared to Rebif® in Healthy Volunteers

Healthy

Russian Federation
Astellas Pharma Inc

Completed

A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients

Urinary Bladder, Overactive

Japan
Astellas Pharma Inc

Completed

Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease

Overactive Bladder | Cardiovascular Disease

Japan
Astellas Pharma Inc

Completed

Drug Use-Results Survey of Betanis Tablets in Japan

Overactive Bladder

Japan
Groupe Francophone des Myelodysplasies
Roche Pharma AG; Celgene Corporation

Completed

Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA)

Myelodysplastic Syndromes

France
Merck KGaA, Darmstadt, Germany
Merck Serono S.P.A., Italy

Completed

A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease (REAL)

Alzheimer's Disease

Italy
Astellas Pharma Inc

Completed

A Study to Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research Subjects

Intraocular Pressure

United States

Search clinical trials for: Beta Carotene

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations